np event 2254995 0E193A 1
Sep 20, 2024
- Sep 19, 2025
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
1.0

Claim your AMA PRA Category 1 Credit

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

Group 39553
Women's Health
Pain Management in Endometriosis: A Primer for NPs and PAs
Group 39553
Nephrology
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult...
Group 39553
Cardiometabolic
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult...